Abbott Laboratories (ABT.N)
ABT.N on New York Stock Exchange
87.76USD
9:05pm BST
87.76USD
9:05pm BST
Change (% chg)
$2.00 (+2.33%)
$2.00 (+2.33%)
Prev Close
$85.76
$85.76
Open
$86.25
$86.25
Day's High
$87.84
$87.84
Day's Low
$85.32
$85.32
Volume
1,665,844
1,665,844
Avg. Vol
1,536,701
1,536,701
52-wk High
$87.84
$87.84
52-wk Low
$62.88
$62.88
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.85 | December | 18 Jul 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 9 | 9 | 9 | 9 |
| (2) OUTPERFORM | 8 | 8 | 8 | 8 |
| (3) HOLD | 2 | 2 | 2 | 2 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.80 | 1.80 | 1.80 | 1.80 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 18 | 8,093.38 | 8,173.00 | 7,998.00 | 8,204.05 |
| Quarter Ending Dec-19 | 18 | 8,337.56 | 8,437.00 | 8,213.60 | 8,493.35 |
| Year Ending Dec-19 | 20 | 31,990.50 | 32,485.00 | 31,843.80 | 32,679.60 |
| Year Ending Dec-20 | 20 | 34,198.70 | 35,078.00 | 33,793.00 | 34,736.20 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 20 | 0.85 | 0.87 | 0.83 | 0.84 |
| Quarter Ending Dec-19 | 20 | 0.94 | 0.96 | 0.91 | 0.92 |
| Year Ending Dec-19 | 21 | 3.22 | 3.24 | 3.20 | 3.21 |
| Year Ending Dec-20 | 22 | 3.60 | 3.68 | 3.48 | 3.60 |
| LT Growth Rate (%) | 5 | 11.63 | 12.70 | 10.80 | 11.68 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-19 | 7,473.78 | 7,535.00 | 61.22 | 0.82 |
| Quarter Ending Dec-18 | 7,816.24 | 7,765.00 | 51.24 | 0.66 |
| Quarter Ending Sep-18 | 7,650.64 | 7,656.00 | 5.36 | 0.07 |
| Quarter Ending Jun-18 | 7,711.53 | 7,767.00 | 55.47 | 0.72 |
| Quarter Ending Mar-18 | 7,285.94 | 7,390.00 | 104.06 | 1.43 |
| Earnings (per share) | ||||
| Quarter Ending Mar-19 | 0.61 | 0.63 | 0.02 | 2.82 |
| Quarter Ending Dec-18 | 0.81 | 0.81 | 0.00 | 0.01 |
| Quarter Ending Sep-18 | 0.75 | 0.75 | 0.00 | 0.58 |
| Quarter Ending Jun-18 | 0.71 | 0.73 | 0.02 | 2.86 |
| Quarter Ending Mar-18 | 0.58 | 0.59 | 0.01 | 1.71 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 8,093.38 | 8,091.55 | 8,091.55 | 8,091.55 | 8,204.05 |
| Quarter Ending Dec-19 | 8,337.56 | 8,336.78 | 8,336.78 | 8,336.78 | 8,493.35 |
| Year Ending Dec-19 | 31,990.50 | 31,987.80 | 31,987.80 | 31,976.80 | 32,679.60 |
| Year Ending Dec-20 | 34,198.70 | 34,195.50 | 34,195.50 | 34,195.50 | 34,736.20 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 0.85 | 0.85 | 0.85 | 0.85 | 0.84 |
| Quarter Ending Dec-19 | 0.94 | 0.94 | 0.94 | 0.94 | 0.92 |
| Year Ending Dec-19 | 3.22 | 3.22 | 3.22 | 3.22 | 3.21 |
| Year Ending Dec-20 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-19 | 1 | 0 | 1 | 0 |
| Quarter Ending Dec-19 | 1 | 0 | 1 | 0 |
| Year Ending Dec-19 | 1 | 0 | 1 | 0 |
| Year Ending Dec-20 | 1 | 0 | 1 | 0 |
| Earnings | ||||
| Quarter Ending Sep-19 | 1 | 1 | 1 | 1 |
| Quarter Ending Dec-19 | 0 | 1 | 0 | 1 |
| Year Ending Dec-19 | 1 | 1 | 1 | 1 |
| Year Ending Dec-20 | 1 | 0 | 1 | 0 |
Earnings vs. 
Estimates- US STOCKS-Wall St falls as CSX results signal damage from trade tensions
- US STOCKS-Wall St falls as CSX results point to damage from trade tensions
- US STOCKS-Wall St falls as railroads slide after CSX signals trade impact
- Abbott hits record high as diabetes device fuels profit beat
- Abbott hits record high as diabetes device fuels profit beat